>> the phenomenon has not been systematically studied.
I think that is an exaggeration. Certainly this issue is something that is systematically studied during the biologics approval process, and something that was even more closely studied in the old days before properly humanized mabs.
Maybe they mean not studied much once a particular drug is approved.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.